Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
5401
5402
5403
5404
5405
5406
5407
5408
5409
5410
5411
5412
5413
5414
5415
5416
5417
5418
5419
5420
5421
5422
5423
5424
5425
5426
5427
5428
5429
5430
5431
5432
5433
5434
5435
5436
5437
5438
5439
5440
5441
5442
5443
5444
5445
5446
5447
5448
5449
5450
5451
5452
5453
5454
5455
5456
5457
5458
5459
5460
5461
5462
5463
5464
5465
5466
5467
5468
5469
5470
5471
5472
5473
5474
5475
5476
5477
5478
5479
5480
5481
5482
5483
5484
5485
5486
5487
5488
5489
5490
5491
5492
5493
5494
5495
5496
5497
5498
5499
5500
5501
5502
5503
5504
5505
5506
5507
5508
5509
5510
5511
5512
5513
5514
5515
5516
5517
5518
5519
5520
5521
5522
5523
5524
5525
5526
5527
5528
5529
5530
5531
5532
5533
5534
5535
5536
5537
5538
5539
5540
5541
5542
5543
5544
5545
5546
5547
5548
5549
5550
5551
5552
5553
5554
5555
5556
5557
5558
5559
5560
5561
5562
5563
5564
5565
5566
5567
5568
5569
5570
5571
5572
5573
5574
5575
5576
5577
5578
5579
5580
5581
5582
5583
5584
5585
5586
5587
5588
5589
5590
5591
5592
5593
5594
5595
5596
5597
5598
5599
5600
| UnnamedSample_HQ_transcript/102986|m.22989 | UnnamedSample_HQ_transcript/102986 | Coverage 0.774 too low. | 8e47a61f03dfc15aba6d823c23d1806c | 211 | Pfam | PF04201 | Tumour protein D52 family | 33 | 112 | 3.5E-18 | T | 22-09-2020 | IPR007327 | Tumour protein D52 |
| UnnamedSample_HQ_transcript/102986|m.22989 | UnnamedSample_HQ_transcript/102986 | Coverage 0.774 too low. | 8e47a61f03dfc15aba6d823c23d1806c | 211 | Pfam | PF04201 | Tumour protein D52 family | 110 | 185 | 5.4E-12 | T | 22-09-2020 | IPR007327 | Tumour protein D52 |
| UnnamedSample_HQ_transcript/81099|m.19901 | UnnamedSample_HQ_transcript/81099 | Coverage 0.151 too low. | 49f0519d4ac9d673d89ea7ee7fafd7e9 | 422 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/2088|m.1090 | UnnamedSample_HQ_transcript/2088 | Coverage 0.324 too low. | 4c29b29e41c35b5f53294d63fe0bf96e | 1153 | Pfam | PF00439 | Bromodomain | 353 | 433 | 4.8E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/92993|m.21661 | UnnamedSample_HQ_transcript/92993 | Coverage 0.956 too low. | d9dee9ae7721b03b4725d4e8c33ab5b8 | 197 | Pfam | PF05753 | Translocon-associated protein beta (TRAPB) | 14 | 186 | 3.1E-62 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/108087|m.23590 | UnnamedSample_HQ_transcript/108087 | Coverage 0.985 too low. | d9dee9ae7721b03b4725d4e8c33ab5b8 | 197 | Pfam | PF05753 | Translocon-associated protein beta (TRAPB) | 14 | 186 | 3.1E-62 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/115635|m.24456 | UnnamedSample_HQ_transcript/115635 | Coverage 0.990 too low. | cd167cd4695c59e336402c7866f39d65 | 201 | Pfam | PF00651 | BTB/POZ domain | 36 | 130 | 1.4E-19 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/38103|m.11420 | UnnamedSample_HQ_transcript/38103 | Coverage 0.655 too low. | f418ff758dca99a691813ec3ae36d01c | 613 | Pfam | PF10222 | Uncharacterized conserved protein (DUF2152) | 13 | 591 | 1.5E-179 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/72123|m.18322 | UnnamedSample_HQ_transcript/72123 | Coverage 0.765 too low. | 94696cb2d8d18f616240c46446ea23ae | 440 | Pfam | PF00096 | Zinc finger, C2H2 type | 391 | 414 | 1.2E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/72123|m.18322 | UnnamedSample_HQ_transcript/72123 | Coverage 0.765 too low. | 94696cb2d8d18f616240c46446ea23ae | 440 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/2179|m.1122 | UnnamedSample_HQ_transcript/2179 | Coverage 0.065 too low. | d8ddb624479cd93570447dbba3aa121d | 600 | Pfam | PF08366 | LLGL2 | 46 | 129 | 3.4E-23 | T | 22-09-2020 | IPR013577 | Lethal giant larvae homologue 2 |
| UnnamedSample_HQ_transcript/46156|m.13178 | UnnamedSample_HQ_transcript/46156 | Coverage 0.273 too low. | 9627a417d30203ddd650126cbab806da | 768 | Pfam | PF05029 | Timeless PAB domain | 551 | 631 | 3.8E-21 | T | 22-09-2020 | IPR007725 | Timeless, C-terminal |
| UnnamedSample_HQ_transcript/20988|m.7143 | UnnamedSample_HQ_transcript/20988 | Coverage 0.820 too low. | fe6daa2e6143c490e095220c8830daf7 | 691 | Pfam | PF00621 | RhoGEF domain | 250 | 431 | 3.8E-41 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/20988|m.7143 | UnnamedSample_HQ_transcript/20988 | Coverage 0.820 too low. | fe6daa2e6143c490e095220c8830daf7 | 691 | Pfam | PF12738 | twin BRCT domain | 1 | 41 | 5.1E-10 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/20988|m.7143 | UnnamedSample_HQ_transcript/20988 | Coverage 0.820 too low. | fe6daa2e6143c490e095220c8830daf7 | 691 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 68 | 139 | 7.2E-6 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/108926|m.23700 | UnnamedSample_HQ_transcript/108926 | Coverage 0.957 too low. | ff65358d72f84eaa2a81f3d6b31692f9 | 204 | Pfam | PF00022 | Actin | 14 | 188 | 5.5E-51 | T | 22-09-2020 | IPR004000 | Actin family |
| UnnamedSample_HQ_transcript/86160|m.20681 | UnnamedSample_HQ_transcript/86160 | Coverage 0.871 too low. | 05591efea8d6ea9d708893c9288c9094 | 105 | Pfam | PF00557 | Metallopeptidase family M24 | 22 | 95 | 2.8E-11 | T | 22-09-2020 | IPR000994 | Peptidase M24 |
| UnnamedSample_HQ_transcript/47971|m.13575 | UnnamedSample_HQ_transcript/47971 | Coverage 0.468 too low. | 29a22211fdca2ce335d82ba24ad183f3 | 370 | Pfam | PF00271 | Helicase conserved C-terminal domain | 223 | 331 | 1.8E-31 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/47971|m.13575 | UnnamedSample_HQ_transcript/47971 | Coverage 0.468 too low. | 29a22211fdca2ce335d82ba24ad183f3 | 370 | Pfam | PF00270 | DEAD/DEAH box helicase | 21 | 186 | 3.5E-45 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/1803|m.979 | UnnamedSample_HQ_transcript/1803 | Identity 0.930 too low. | cd3203dd0353574fe3f263dbbbf8e561 | 1594 | Pfam | PF15336 | Autism susceptibility gene 2 protein | 1265 | 1361 | 2.7E-5 | T | 22-09-2020 | IPR023246 | Autism susceptibility gene 2 protein |
| UnnamedSample_HQ_transcript/1803|m.979 | UnnamedSample_HQ_transcript/1803 | Identity 0.930 too low. | cd3203dd0353574fe3f263dbbbf8e561 | 1594 | Pfam | PF15336 | Autism susceptibility gene 2 protein | 1183 | 1262 | 1.6E-10 | T | 22-09-2020 | IPR023246 | Autism susceptibility gene 2 protein |
| UnnamedSample_HQ_transcript/1154|m.706 | UnnamedSample_HQ_transcript/1154 | Identity 0.925 too low. | cd3203dd0353574fe3f263dbbbf8e561 | 1594 | Pfam | PF15336 | Autism susceptibility gene 2 protein | 1265 | 1361 | 2.7E-5 | T | 22-09-2020 | IPR023246 | Autism susceptibility gene 2 protein |
| UnnamedSample_HQ_transcript/1154|m.706 | UnnamedSample_HQ_transcript/1154 | Identity 0.925 too low. | cd3203dd0353574fe3f263dbbbf8e561 | 1594 | Pfam | PF15336 | Autism susceptibility gene 2 protein | 1183 | 1262 | 1.6E-10 | T | 22-09-2020 | IPR023246 | Autism susceptibility gene 2 protein |
| UnnamedSample_HQ_transcript/44321|m.12777 | UnnamedSample_HQ_transcript/44321 | Coverage 0.971 too low. | 3d501314f4f64808d0571f797e7da9bd | 697 | Pfam | PF00063 | Myosin head (motor domain) | 1 | 600 | 6.4E-246 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/3623|m.1660 | UnnamedSample_HQ_transcript/3623 | Unmapped. | 304fd040c07f94532585993cdc08114a | 1707 | Pfam | PF00270 | DEAD/DEAH box helicase | 1054 | 1213 | 3.3E-9 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/60363|m.16133 | UnnamedSample_HQ_transcript/60363 | Identity 0.827 too low. | a8e7cfc50f0712bc6102cbcd921e5039 | 265 | Pfam | PF00017 | SH2 domain | 77 | 155 | 2.8E-10 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/53320|m.14704 | UnnamedSample_HQ_transcript/53320 | Identity 0.844 too low. | a8e7cfc50f0712bc6102cbcd921e5039 | 265 | Pfam | PF00017 | SH2 domain | 77 | 155 | 2.8E-10 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/16304|m.5796 | UnnamedSample_HQ_transcript/16304 | Coverage 0.789 too low. | 7cad2b2184c0e8c140fc2ecbdc75cc15 | 1009 | Pfam | PF17787 | PH domain | 12 | 139 | 1.8E-44 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/16304|m.5796 | UnnamedSample_HQ_transcript/16304 | Coverage 0.789 too low. | 7cad2b2184c0e8c140fc2ecbdc75cc15 | 1009 | Pfam | PF00387 | Phosphatidylinositol-specific phospholipase C, Y domain | 592 | 705 | 1.6E-39 | T | 22-09-2020 | IPR001711 | Phospholipase C, phosphatidylinositol-specific, Y domain |
| UnnamedSample_HQ_transcript/16304|m.5796 | UnnamedSample_HQ_transcript/16304 | Coverage 0.789 too low. | 7cad2b2184c0e8c140fc2ecbdc75cc15 | 1009 | Pfam | PF00388 | Phosphatidylinositol-specific phospholipase C, X domain | 319 | 466 | 6.8E-60 | T | 22-09-2020 | IPR000909 | Phosphatidylinositol-specific phospholipase C, X domain |
| UnnamedSample_HQ_transcript/16304|m.5796 | UnnamedSample_HQ_transcript/16304 | Coverage 0.789 too low. | 7cad2b2184c0e8c140fc2ecbdc75cc15 | 1009 | Pfam | PF09279 | Phosphoinositide-specific phospholipase C, efhand-like | 212 | 308 | 6.3E-11 | T | 22-09-2020 | IPR015359 | Phosphoinositide-specific phospholipase C, EF-hand-like domain |
| UnnamedSample_HQ_transcript/6040|m.2556 | UnnamedSample_HQ_transcript/6040 | Identity 0.822 too low. | 4656428d5364f7b08288f9eac29858f2 | 718 | Pfam | PF00041 | Fibronectin type III domain | 427 | 512 | 2.6E-14 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6040|m.2556 | UnnamedSample_HQ_transcript/6040 | Identity 0.822 too low. | 4656428d5364f7b08288f9eac29858f2 | 718 | Pfam | PF00041 | Fibronectin type III domain | 642 | 714 | 3.5E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6040|m.2556 | UnnamedSample_HQ_transcript/6040 | Identity 0.822 too low. | 4656428d5364f7b08288f9eac29858f2 | 718 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 216 | 4.4E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/6040|m.2556 | UnnamedSample_HQ_transcript/6040 | Identity 0.822 too low. | 4656428d5364f7b08288f9eac29858f2 | 718 | Pfam | PF07679 | Immunoglobulin I-set domain | 39 | 127 | 6.2E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/6040|m.2556 | UnnamedSample_HQ_transcript/6040 | Identity 0.822 too low. | 4656428d5364f7b08288f9eac29858f2 | 718 | Pfam | PF07679 | Immunoglobulin I-set domain | 322 | 407 | 7.5E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/6040|m.2556 | UnnamedSample_HQ_transcript/6040 | Identity 0.822 too low. | 4656428d5364f7b08288f9eac29858f2 | 718 | Pfam | PF07679 | Immunoglobulin I-set domain | 220 | 311 | 3.2E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/10913|m.4117 | UnnamedSample_HQ_transcript/10913 | Unmapped. | d750d671f214c810b5ff2003f08da557 | 539 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 8 | 377 | 2.5E-10 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/98851|m.22475 | UnnamedSample_HQ_transcript/98851 | Coverage 0.394 too low. | 4b875a9c62678c8b7aed29cb415c5789 | 337 | Pfam | PF00107 | Zinc-binding dehydrogenase | 160 | 288 | 3.4E-17 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/98851|m.22475 | UnnamedSample_HQ_transcript/98851 | Coverage 0.394 too low. | 4b875a9c62678c8b7aed29cb415c5789 | 337 | Pfam | PF16884 | N-terminal domain of oxidoreductase | 5 | 103 | 7.7E-27 | T | 22-09-2020 | IPR041694 | Oxidoreductase, N-terminal domain |
| UnnamedSample_HQ_transcript/91580|m.21486 | UnnamedSample_HQ_transcript/91580 | Coverage 0.343 too low. | 4b875a9c62678c8b7aed29cb415c5789 | 337 | Pfam | PF00107 | Zinc-binding dehydrogenase | 160 | 288 | 3.4E-17 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/91580|m.21486 | UnnamedSample_HQ_transcript/91580 | Coverage 0.343 too low. | 4b875a9c62678c8b7aed29cb415c5789 | 337 | Pfam | PF16884 | N-terminal domain of oxidoreductase | 5 | 103 | 7.7E-27 | T | 22-09-2020 | IPR041694 | Oxidoreductase, N-terminal domain |
| UnnamedSample_HQ_transcript/36761|m.11105 | UnnamedSample_HQ_transcript/36761 | Coverage 0.974 too low. | ec333347d2f89438eb680f0fd0664085 | 505 | Pfam | PF13329 | Autophagy-related protein 2 CAD motif | 70 | 193 | 8.3E-7 | T | 22-09-2020 | IPR026885 | Autophagy-related protein 2, CAD motif |
| UnnamedSample_HQ_transcript/69392|m.17829 | UnnamedSample_HQ_transcript/69392 | Coverage 0.987 too low. | 738019a2f650d6a68c750c09d9e9da6e | 563 | Pfam | PF08142 | AARP2CN (NUC121) domain | 234 | 319 | 6.8E-32 | T | 22-09-2020 | IPR012948 | AARP2CN |
| UnnamedSample_HQ_transcript/18495|m.6446 | UnnamedSample_HQ_transcript/18495 | Coverage 0.912 too low. | 63161c056dd3ae136b3fb66c4258b9e8 | 693 | Pfam | PF00412 | LIM domain | 605 | 660 | 3.2E-11 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/18495|m.6446 | UnnamedSample_HQ_transcript/18495 | Coverage 0.912 too low. | 63161c056dd3ae136b3fb66c4258b9e8 | 693 | Pfam | PF00412 | LIM domain | 4 | 46 | 1.4E-10 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/5088|m.2229 | UnnamedSample_HQ_transcript/5088 | Unmapped. | b9be6fe4421eff47992ba62b3bcd24b9 | 1531 | Pfam | PF00910 | RNA helicase | 1152 | 1260 | 5.5E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/5088|m.2229 | UnnamedSample_HQ_transcript/5088 | Unmapped. | b9be6fe4421eff47992ba62b3bcd24b9 | 1531 | Pfam | PF08762 | CRPV capsid protein like | 528 | 738 | 8.3E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/30085|m.9496 | UnnamedSample_HQ_transcript/30085 | Coverage 0.711 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 491 | 547 | 6.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30085|m.9496 | UnnamedSample_HQ_transcript/30085 | Coverage 0.711 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 228 | 286 | 2.1E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30085|m.9496 | UnnamedSample_HQ_transcript/30085 | Coverage 0.711 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 442 | 498 | 3.6E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30085|m.9496 | UnnamedSample_HQ_transcript/30085 | Coverage 0.711 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 4 | 60 | 5.2E-10 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30085|m.9496 | UnnamedSample_HQ_transcript/30085 | Coverage 0.711 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 101 | 156 | 1.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30085|m.9496 | UnnamedSample_HQ_transcript/30085 | Coverage 0.711 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 42 | 99 | 2.0E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30085|m.9496 | UnnamedSample_HQ_transcript/30085 | Coverage 0.711 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 166 | 220 | 1.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30085|m.9496 | UnnamedSample_HQ_transcript/30085 | Coverage 0.711 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 559 | 662 | 1.5E-37 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/30085|m.9496 | UnnamedSample_HQ_transcript/30085 | Coverage 0.711 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 667 | 777 | 1.4E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/21789|m.7367 | UnnamedSample_HQ_transcript/21789 | Coverage 0.629 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 491 | 547 | 6.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/21789|m.7367 | UnnamedSample_HQ_transcript/21789 | Coverage 0.629 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 228 | 286 | 2.1E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/21789|m.7367 | UnnamedSample_HQ_transcript/21789 | Coverage 0.629 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 442 | 498 | 3.6E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/21789|m.7367 | UnnamedSample_HQ_transcript/21789 | Coverage 0.629 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 4 | 60 | 5.2E-10 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/21789|m.7367 | UnnamedSample_HQ_transcript/21789 | Coverage 0.629 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 101 | 156 | 1.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/21789|m.7367 | UnnamedSample_HQ_transcript/21789 | Coverage 0.629 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 42 | 99 | 2.0E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/21789|m.7367 | UnnamedSample_HQ_transcript/21789 | Coverage 0.629 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 166 | 220 | 1.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/21789|m.7367 | UnnamedSample_HQ_transcript/21789 | Coverage 0.629 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 559 | 662 | 1.5E-37 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/21789|m.7367 | UnnamedSample_HQ_transcript/21789 | Coverage 0.629 too low. | f4ff6336d1c789f113eab62d42fd6dcf | 779 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 667 | 777 | 1.4E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/17949|m.6287 | UnnamedSample_HQ_transcript/17949 | Coverage 0.163 too low. | 58e102ba36f6f0ed5e7e482c927097fa | 1033 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 790 | 835 | 3.8E-7 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/17949|m.6287 | UnnamedSample_HQ_transcript/17949 | Coverage 0.163 too low. | 58e102ba36f6f0ed5e7e482c927097fa | 1033 | Pfam | PF00063 | Myosin head (motor domain) | 243 | 378 | 1.5E-32 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/17949|m.6287 | UnnamedSample_HQ_transcript/17949 | Coverage 0.163 too low. | 58e102ba36f6f0ed5e7e482c927097fa | 1033 | Pfam | PF00612 | IQ calmodulin-binding motif | 469 | 486 | 0.012 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/17949|m.6287 | UnnamedSample_HQ_transcript/17949 | Coverage 0.163 too low. | 58e102ba36f6f0ed5e7e482c927097fa | 1033 | Pfam | PF00612 | IQ calmodulin-binding motif | 417 | 434 | 0.033 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/17949|m.6287 | UnnamedSample_HQ_transcript/17949 | Coverage 0.163 too low. | 58e102ba36f6f0ed5e7e482c927097fa | 1033 | Pfam | PF00612 | IQ calmodulin-binding motif | 444 | 463 | 0.17 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/25269|m.8280 | UnnamedSample_HQ_transcript/25269 | Coverage 0.813 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/13422|m.4932 | UnnamedSample_HQ_transcript/13422 | Coverage 0.772 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/14632|m.5300 | UnnamedSample_HQ_transcript/14632 | Coverage 0.744 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/28879|m.9193 | UnnamedSample_HQ_transcript/28879 | Coverage 0.690 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/27666|m.8877 | UnnamedSample_HQ_transcript/27666 | Coverage 0.675 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/7126|m.2902 | UnnamedSample_HQ_transcript/7126 | Coverage 0.620 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/18990|m.6576 | UnnamedSample_HQ_transcript/18990 | Identity 0.728 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/7888|m.3151 | UnnamedSample_HQ_transcript/7888 | Coverage 0.631 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/27299|m.8791 | UnnamedSample_HQ_transcript/27299 | Coverage 0.666 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/10533|m.3999 | UnnamedSample_HQ_transcript/10533 | Coverage 0.680 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/25579|m.8364 | UnnamedSample_HQ_transcript/25579 | Coverage 0.655 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/26097|m.8507 | UnnamedSample_HQ_transcript/26097 | Identity 0.695 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/28469|m.9084 | UnnamedSample_HQ_transcript/28469 | Coverage 0.671 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/11779|m.4420 | UnnamedSample_HQ_transcript/11779 | Coverage 0.704 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/30134|m.9507 | UnnamedSample_HQ_transcript/30134 | Coverage 0.403 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/16565|m.5881 | UnnamedSample_HQ_transcript/16565 | Coverage 0.785 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/13032|m.4827 | UnnamedSample_HQ_transcript/13032 | Coverage 0.726 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/26011|m.8481 | UnnamedSample_HQ_transcript/26011 | Coverage 0.656 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/28147|m.9005 | UnnamedSample_HQ_transcript/28147 | Coverage 0.681 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/14227|m.5180 | UnnamedSample_HQ_transcript/14227 | Coverage 0.749 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/34154|m.10506 | UnnamedSample_HQ_transcript/34154 | Coverage 0.420 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/24978|m.8216 | UnnamedSample_HQ_transcript/24978 | Coverage 0.664 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/19093|m.6609 | UnnamedSample_HQ_transcript/19093 | Coverage 0.596 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/11977|m.4487 | UnnamedSample_HQ_transcript/11977 | Coverage 0.708 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/22058|m.7442 | UnnamedSample_HQ_transcript/22058 | Coverage 0.703 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/14164|m.5159 | UnnamedSample_HQ_transcript/14164 | Coverage 0.303 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/18329|m.6401 | UnnamedSample_HQ_transcript/18329 | Coverage 0.730 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/12847|m.4772 | UnnamedSample_HQ_transcript/12847 | Coverage 0.724 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/11687|m.4387 | UnnamedSample_HQ_transcript/11687 | Coverage 0.656 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/15372|m.5514 | UnnamedSample_HQ_transcript/15372 | Identity 0.750 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/8945|m.3498 | UnnamedSample_HQ_transcript/8945 | Identity 0.745 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/23517|m.7807 | UnnamedSample_HQ_transcript/23517 | Coverage 0.652 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/27485|m.8827 | UnnamedSample_HQ_transcript/27485 | Coverage 0.671 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/10044|m.3845 | UnnamedSample_HQ_transcript/10044 | Coverage 0.671 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/13196|m.4868 | UnnamedSample_HQ_transcript/13196 | Coverage 0.728 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/21069|m.7160 | UnnamedSample_HQ_transcript/21069 | Coverage 0.632 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/14158|m.5156 | UnnamedSample_HQ_transcript/14158 | Identity 0.755 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/29577|m.9372 | UnnamedSample_HQ_transcript/29577 | Coverage 0.679 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/23398|m.7786 | UnnamedSample_HQ_transcript/23398 | Coverage 0.670 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/18374|m.6415 | UnnamedSample_HQ_transcript/18374 | Identity 0.732 too low. | 9189895ff0f0874e0fa490d86568c17e | 404 | Pfam | PF00102 | Protein-tyrosine phosphatase | 131 | 377 | 3.9E-82 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/51695|m.14386 | UnnamedSample_HQ_transcript/51695 | Coverage 0.985 too low. | 7fe8d97aea1176bde2f0865cb2cb9638 | 662 | Pfam | PF06733 | DEAD_2 | 114 | 275 | 8.4E-51 | T | 22-09-2020 | IPR010614 | DEAD2 |
| UnnamedSample_HQ_transcript/51695|m.14386 | UnnamedSample_HQ_transcript/51695 | Coverage 0.985 too low. | 7fe8d97aea1176bde2f0865cb2cb9638 | 662 | Pfam | PF13307 | Helicase C-terminal domain | 544 | 661 | 2.9E-32 | T | 22-09-2020 | IPR006555 | ATP-dependent helicase, C-terminal |
| UnnamedSample_HQ_transcript/24498|m.8067 | UnnamedSample_HQ_transcript/24498 | Coverage 0.927 too low. | 0a4150c5c89ed1dcf9a0fcdb2b6e0add | 275 | Pfam | PF04097 | Nup93/Nic96 | 5 | 270 | 1.4E-78 | T | 22-09-2020 | IPR007231 | Nucleoporin interacting component Nup93/Nic96 |
| UnnamedSample_HQ_transcript/1622|m.902 | UnnamedSample_HQ_transcript/1622 | Coverage 0.980 too low. | 6c9d097d376e0c037e7294151caab48c | 1805 | Pfam | PF00094 | von Willebrand factor type D domain | 1256 | 1394 | 9.8E-7 | T | 22-09-2020 | IPR001846 | von Willebrand factor, type D domain |
| UnnamedSample_HQ_transcript/43210|m.12534 | UnnamedSample_HQ_transcript/43210 | Coverage 0.382 too low. | 4bcdfbb74691ef4bfc55c8b8208998db | 267 | Pfam | PF00665 | Integrase core domain | 27 | 119 | 5.3E-10 | T | 22-09-2020 | IPR001584 | Integrase, catalytic core |
| UnnamedSample_HQ_transcript/70961|m.18101 | UnnamedSample_HQ_transcript/70961 | Coverage 0.876 too low. | 363a787cde099b70836eee2c2b389d94 | 285 | Pfam | PF02179 | BAG domain | 161 | 233 | 8.0E-18 | T | 22-09-2020 | IPR003103 | BAG domain |
| UnnamedSample_HQ_transcript/26475|m.8598 | UnnamedSample_HQ_transcript/26475 | Coverage 0.497 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF00795 | Carbon-nitrogen hydrolase | 7 | 282 | 1.8E-36 | T | 22-09-2020 | IPR003010 | Carbon-nitrogen hydrolase |
| UnnamedSample_HQ_transcript/26475|m.8598 | UnnamedSample_HQ_transcript/26475 | Coverage 0.497 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF02540 | NAD synthase | 340 | 600 | 1.9E-25 | T | 22-09-2020 | IPR022310 | NAD/GMP synthase |
| UnnamedSample_HQ_transcript/22612|m.7593 | UnnamedSample_HQ_transcript/22612 | Coverage 0.504 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF00795 | Carbon-nitrogen hydrolase | 7 | 282 | 1.8E-36 | T | 22-09-2020 | IPR003010 | Carbon-nitrogen hydrolase |
| UnnamedSample_HQ_transcript/22612|m.7593 | UnnamedSample_HQ_transcript/22612 | Coverage 0.504 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF02540 | NAD synthase | 340 | 600 | 1.9E-25 | T | 22-09-2020 | IPR022310 | NAD/GMP synthase |
| UnnamedSample_HQ_transcript/22507|m.7575 | UnnamedSample_HQ_transcript/22507 | Coverage 0.053 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF00795 | Carbon-nitrogen hydrolase | 7 | 282 | 1.8E-36 | T | 22-09-2020 | IPR003010 | Carbon-nitrogen hydrolase |
| UnnamedSample_HQ_transcript/22507|m.7575 | UnnamedSample_HQ_transcript/22507 | Coverage 0.053 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF02540 | NAD synthase | 340 | 600 | 1.9E-25 | T | 22-09-2020 | IPR022310 | NAD/GMP synthase |
| UnnamedSample_HQ_transcript/24257|m.8011 | UnnamedSample_HQ_transcript/24257 | Coverage 0.489 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF00795 | Carbon-nitrogen hydrolase | 7 | 282 | 1.8E-36 | T | 22-09-2020 | IPR003010 | Carbon-nitrogen hydrolase |
| UnnamedSample_HQ_transcript/24257|m.8011 | UnnamedSample_HQ_transcript/24257 | Coverage 0.489 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF02540 | NAD synthase | 340 | 600 | 1.9E-25 | T | 22-09-2020 | IPR022310 | NAD/GMP synthase |
| UnnamedSample_HQ_transcript/21932|m.7411 | UnnamedSample_HQ_transcript/21932 | Coverage 0.492 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF00795 | Carbon-nitrogen hydrolase | 7 | 282 | 1.8E-36 | T | 22-09-2020 | IPR003010 | Carbon-nitrogen hydrolase |
| UnnamedSample_HQ_transcript/21932|m.7411 | UnnamedSample_HQ_transcript/21932 | Coverage 0.492 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF02540 | NAD synthase | 340 | 600 | 1.9E-25 | T | 22-09-2020 | IPR022310 | NAD/GMP synthase |
| UnnamedSample_HQ_transcript/31639|m.9862 | UnnamedSample_HQ_transcript/31639 | Coverage 0.435 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF00795 | Carbon-nitrogen hydrolase | 7 | 282 | 1.8E-36 | T | 22-09-2020 | IPR003010 | Carbon-nitrogen hydrolase |
| UnnamedSample_HQ_transcript/31639|m.9862 | UnnamedSample_HQ_transcript/31639 | Coverage 0.435 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF02540 | NAD synthase | 340 | 600 | 1.9E-25 | T | 22-09-2020 | IPR022310 | NAD/GMP synthase |
| UnnamedSample_HQ_transcript/17693|m.6220 | UnnamedSample_HQ_transcript/17693 | Coverage 0.469 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF00795 | Carbon-nitrogen hydrolase | 7 | 282 | 1.8E-36 | T | 22-09-2020 | IPR003010 | Carbon-nitrogen hydrolase |
| UnnamedSample_HQ_transcript/17693|m.6220 | UnnamedSample_HQ_transcript/17693 | Coverage 0.469 too low. | e04d89ac1adf887530dd7c25a9d57d17 | 774 | Pfam | PF02540 | NAD synthase | 340 | 600 | 1.9E-25 | T | 22-09-2020 | IPR022310 | NAD/GMP synthase |
| UnnamedSample_HQ_transcript/21040|m.7155 | UnnamedSample_HQ_transcript/21040 | Coverage 0.841 too low. | ed23f6b56fac68bfa5c6266c8deda211 | 487 | Pfam | PF13855 | Leucine rich repeat | 93 | 153 | 4.7E-7 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/21040|m.7155 | UnnamedSample_HQ_transcript/21040 | Coverage 0.841 too low. | ed23f6b56fac68bfa5c6266c8deda211 | 487 | Pfam | PF13855 | Leucine rich repeat | 190 | 250 | 2.1E-14 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/21040|m.7155 | UnnamedSample_HQ_transcript/21040 | Coverage 0.841 too low. | ed23f6b56fac68bfa5c6266c8deda211 | 487 | Pfam | PF13855 | Leucine rich repeat | 262 | 322 | 2.3E-12 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/22651|m.7605 | UnnamedSample_HQ_transcript/22651 | Coverage 0.880 too low. | ed23f6b56fac68bfa5c6266c8deda211 | 487 | Pfam | PF13855 | Leucine rich repeat | 93 | 153 | 4.7E-7 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/22651|m.7605 | UnnamedSample_HQ_transcript/22651 | Coverage 0.880 too low. | ed23f6b56fac68bfa5c6266c8deda211 | 487 | Pfam | PF13855 | Leucine rich repeat | 190 | 250 | 2.1E-14 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/22651|m.7605 | UnnamedSample_HQ_transcript/22651 | Coverage 0.880 too low. | ed23f6b56fac68bfa5c6266c8deda211 | 487 | Pfam | PF13855 | Leucine rich repeat | 262 | 322 | 2.3E-12 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/13658|m.5003 | UnnamedSample_HQ_transcript/13658 | Coverage 0.165 too low. | afacb2d983b79747b14d7743fe8b0201 | 589 | Pfam | PF13927 | Immunoglobulin domain | 500 | 569 | 2.3E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/13658|m.5003 | UnnamedSample_HQ_transcript/13658 | Coverage 0.165 too low. | afacb2d983b79747b14d7743fe8b0201 | 589 | Pfam | PF13927 | Immunoglobulin domain | 13 | 89 | 1.5E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/13658|m.5003 | UnnamedSample_HQ_transcript/13658 | Coverage 0.165 too low. | afacb2d983b79747b14d7743fe8b0201 | 589 | Pfam | PF13895 | Immunoglobulin domain | 215 | 290 | 1.4E-7 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/82655|m.20143 | UnnamedSample_HQ_transcript/82655 | Coverage 0.504 too low. | fb2fd790eb6ad075a1450cb9408d143d | 184 | Pfam | PF03194 | LUC7 N_terminus | 1 | 108 | 1.2E-35 | T | 22-09-2020 | IPR004882 | Luc7-related |
| UnnamedSample_HQ_transcript/49201|m.13852 | UnnamedSample_HQ_transcript/49201 | Coverage 0.710 too low. | 83ecde2e7cb45502cbab6eaadddbd49f | 339 | Pfam | PF00351 | Biopterin-dependent aromatic amino acid hydroxylase | 115 | 322 | 2.4E-115 | T | 22-09-2020 | IPR019774 | Aromatic amino acid hydroxylase, C-terminal |
| UnnamedSample_HQ_transcript/52105|m.14476 | UnnamedSample_HQ_transcript/52105 | Coverage 0.092 too low. | 72e851258041b0197a1838f66a90a310 | 359 | Pfam | PF15361 | Resistance to inhibitors of cholinesterase homologue 3 | 13 | 111 | 2.4E-9 | T | 22-09-2020 | IPR032763 | Resistance to inhibitors of cholinesterase protein 3, N-terminal |
| UnnamedSample_HQ_transcript/48923|m.13782 | UnnamedSample_HQ_transcript/48923 | Coverage 0.893 too low. | 8bb229500a6634dec70cf64faba00ba3 | 536 | Pfam | PF00617 | RasGEF domain | 61 | 225 | 5.5E-51 | T | 22-09-2020 | IPR001895 | Ras guanine-nucleotide exchange factors catalytic domain |
| UnnamedSample_HQ_transcript/48923|m.13782 | UnnamedSample_HQ_transcript/48923 | Coverage 0.893 too low. | 8bb229500a6634dec70cf64faba00ba3 | 536 | Pfam | PF00169 | PH domain | 415 | 520 | 5.0E-6 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/39219|m.11695 | UnnamedSample_HQ_transcript/39219 | Unmapped. | 6f1927cef6808d65ee4e5e30f86696a4 | 771 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 375 | 742 | 6.7E-10 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/20923|m.7128 | UnnamedSample_HQ_transcript/20923 | Coverage 0.782 too low. | 7021a9476eb66f0e0a4fb04c6398f650 | 166 | Pfam | PF13855 | Leucine rich repeat | 114 | 166 | 1.7E-8 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/22078|m.7450 | UnnamedSample_HQ_transcript/22078 | Coverage 0.565 too low. | 9acea4a5cc6b6d37ff27a1b08a33b518 | 1026 | Pfam | PF16589 | BRCT domain, a BRCA1 C-terminus domain | 587 | 668 | 3.4E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/22078|m.7450 | UnnamedSample_HQ_transcript/22078 | Coverage 0.565 too low. | 9acea4a5cc6b6d37ff27a1b08a33b518 | 1026 | Pfam | PF12738 | twin BRCT domain | 212 | 273 | 3.1E-13 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/22078|m.7450 | UnnamedSample_HQ_transcript/22078 | Coverage 0.565 too low. | 9acea4a5cc6b6d37ff27a1b08a33b518 | 1026 | Pfam | PF12738 | twin BRCT domain | 116 | 175 | 6.3E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/22078|m.7450 | UnnamedSample_HQ_transcript/22078 | Coverage 0.565 too low. | 9acea4a5cc6b6d37ff27a1b08a33b518 | 1026 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 679 | 761 | 2.9E-13 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/22078|m.7450 | UnnamedSample_HQ_transcript/22078 | Coverage 0.565 too low. | 9acea4a5cc6b6d37ff27a1b08a33b518 | 1026 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 403 | 477 | 5.4E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/4617|m.2043 | UnnamedSample_HQ_transcript/4617 | Coverage 0.963 too low. | 3fa003e4901c34b549ef02be79647e4f | 1211 | Pfam | PF17921 | Integrase zinc binding domain | 832 | 888 | 8.2E-16 | T | 22-09-2020 | IPR041588 | Integrase zinc-binding domain |
| UnnamedSample_HQ_transcript/4617|m.2043 | UnnamedSample_HQ_transcript/4617 | Coverage 0.963 too low. | 3fa003e4901c34b549ef02be79647e4f | 1211 | Pfam | PF17917 | RNase H-like domain found in reverse transcriptase | 639 | 744 | 4.5E-29 | T | 22-09-2020 | IPR041373 | Reverse transcriptase, RNase H-like domain |
| UnnamedSample_HQ_transcript/4617|m.2043 | UnnamedSample_HQ_transcript/4617 | Coverage 0.963 too low. | 3fa003e4901c34b549ef02be79647e4f | 1211 | Pfam | PF00665 | Integrase core domain | 905 | 1001 | 4.2E-11 | T | 22-09-2020 | IPR001584 | Integrase, catalytic core |
| UnnamedSample_HQ_transcript/4617|m.2043 | UnnamedSample_HQ_transcript/4617 | Coverage 0.963 too low. | 3fa003e4901c34b549ef02be79647e4f | 1211 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 394 | 551 | 3.6E-16 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/8264|m.3279 | UnnamedSample_HQ_transcript/8264 | Coverage 0.254 too low. | db8c23921ce253b5e8a01dc00310083a | 852 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 232 | 406 | 3.1E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/8264|m.3279 | UnnamedSample_HQ_transcript/8264 | Coverage 0.254 too low. | db8c23921ce253b5e8a01dc00310083a | 852 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 62 | 131 | 5.0E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/47296|m.13429 | UnnamedSample_HQ_transcript/47296 | Unmapped. | 39767ec6a3a662913cd9237bb70ac1e1 | 748 | Pfam | PF00562 | RNA polymerase Rpb2, domain 6 | 289 | 719 | 3.5E-121 | T | 22-09-2020 | IPR007120 | DNA-directed RNA polymerase, subunit 2, hybrid-binding domain |
| UnnamedSample_HQ_transcript/47296|m.13429 | UnnamedSample_HQ_transcript/47296 | Unmapped. | 39767ec6a3a662913cd9237bb70ac1e1 | 748 | Pfam | PF10385 | RNA polymerase beta subunit external 1 domain | 163 | 228 | 1.8E-25 | T | 22-09-2020 | IPR019462 | DNA-directed RNA polymerase, beta subunit, external 1 domain |
| UnnamedSample_HQ_transcript/47296|m.13429 | UnnamedSample_HQ_transcript/47296 | Unmapped. | 39767ec6a3a662913cd9237bb70ac1e1 | 748 | Pfam | PF04565 | RNA polymerase Rpb2, domain 3 | 85 | 152 | 7.9E-30 | T | 22-09-2020 | IPR007645 | RNA polymerase Rpb2, domain 3 |
| UnnamedSample_HQ_transcript/47296|m.13429 | UnnamedSample_HQ_transcript/47296 | Unmapped. | 39767ec6a3a662913cd9237bb70ac1e1 | 748 | Pfam | PF04563 | RNA polymerase beta subunit | 25 | 72 | 8.0E-9 | T | 22-09-2020 | IPR007644 | RNA polymerase, beta subunit, protrusion |
| UnnamedSample_HQ_transcript/106339|m.23377 | UnnamedSample_HQ_transcript/106339 | Coverage 0.813 too low. | 2c2b812af3ca6e24def78de8569622fa | 226 | Pfam | PF02210 | Laminin G domain | 78 | 205 | 1.9E-21 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/66344|m.17278 | UnnamedSample_HQ_transcript/66344 | Coverage 0.472 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00581 | Rhodanese-like domain | 112 | 216 | 3.5E-7 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/66344|m.17278 | UnnamedSample_HQ_transcript/66344 | Coverage 0.472 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 291 | 421 | 4.9E-41 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/48059|m.13591 | UnnamedSample_HQ_transcript/48059 | Coverage 0.600 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00581 | Rhodanese-like domain | 112 | 216 | 3.5E-7 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/48059|m.13591 | UnnamedSample_HQ_transcript/48059 | Coverage 0.600 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 291 | 421 | 4.9E-41 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/45884|m.13113 | UnnamedSample_HQ_transcript/45884 | Coverage 0.646 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00581 | Rhodanese-like domain | 112 | 216 | 3.5E-7 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/45884|m.13113 | UnnamedSample_HQ_transcript/45884 | Coverage 0.646 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 291 | 421 | 4.9E-41 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/34253|m.10532 | UnnamedSample_HQ_transcript/34253 | Coverage 0.681 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00581 | Rhodanese-like domain | 112 | 216 | 3.5E-7 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/34253|m.10532 | UnnamedSample_HQ_transcript/34253 | Coverage 0.681 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 291 | 421 | 4.9E-41 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/10919|m.4122 | UnnamedSample_HQ_transcript/10919 | Coverage 0.740 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00581 | Rhodanese-like domain | 112 | 216 | 3.5E-7 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/10919|m.4122 | UnnamedSample_HQ_transcript/10919 | Coverage 0.740 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 291 | 421 | 4.9E-41 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/42874|m.12458 | UnnamedSample_HQ_transcript/42874 | Coverage 0.570 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00581 | Rhodanese-like domain | 112 | 216 | 3.5E-7 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/42874|m.12458 | UnnamedSample_HQ_transcript/42874 | Coverage 0.570 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 291 | 421 | 4.9E-41 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/7098|m.2891 | UnnamedSample_HQ_transcript/7098 | Coverage 0.779 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00581 | Rhodanese-like domain | 112 | 216 | 3.5E-7 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/7098|m.2891 | UnnamedSample_HQ_transcript/7098 | Coverage 0.779 too low. | e88e03f8efbc9f65371b92ba7beeb29d | 467 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 291 | 421 | 4.9E-41 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/72067|m.18314 | UnnamedSample_HQ_transcript/72067 | Coverage 0.983 too low. | 00ba4e1fb3f21d6ae683a7d7926b7d56 | 516 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 36 | 500 | 1.6E-80 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/16841|m.5955 | UnnamedSample_HQ_transcript/16841 | Coverage 0.041 too low. | 0720936e56257bdbc569cfedfe603cf4 | 1089 | Pfam | PF02898 | Nitric oxide synthase, oxygenase domain | 14 | 375 | 4.2E-185 | T | 22-09-2020 | IPR004030 | Nitric oxide synthase, N-terminal |
| UnnamedSample_HQ_transcript/16841|m.5955 | UnnamedSample_HQ_transcript/16841 | Coverage 0.041 too low. | 0720936e56257bdbc569cfedfe603cf4 | 1089 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 914 | 1025 | 1.4E-15 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/16841|m.5955 | UnnamedSample_HQ_transcript/16841 | Coverage 0.041 too low. | 0720936e56257bdbc569cfedfe603cf4 | 1089 | Pfam | PF00258 | Flavodoxin | 423 | 603 | 9.7E-53 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/16841|m.5955 | UnnamedSample_HQ_transcript/16841 | Coverage 0.041 too low. | 0720936e56257bdbc569cfedfe603cf4 | 1089 | Pfam | PF00667 | FAD binding domain | 659 | 882 | 2.0E-62 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/17258|m.6080 | UnnamedSample_HQ_transcript/17258 | Coverage 0.042 too low. | 0720936e56257bdbc569cfedfe603cf4 | 1089 | Pfam | PF02898 | Nitric oxide synthase, oxygenase domain | 14 | 375 | 4.2E-185 | T | 22-09-2020 | IPR004030 | Nitric oxide synthase, N-terminal |
| UnnamedSample_HQ_transcript/17258|m.6080 | UnnamedSample_HQ_transcript/17258 | Coverage 0.042 too low. | 0720936e56257bdbc569cfedfe603cf4 | 1089 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 914 | 1025 | 1.4E-15 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/17258|m.6080 | UnnamedSample_HQ_transcript/17258 | Coverage 0.042 too low. | 0720936e56257bdbc569cfedfe603cf4 | 1089 | Pfam | PF00258 | Flavodoxin | 423 | 603 | 9.7E-53 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/17258|m.6080 | UnnamedSample_HQ_transcript/17258 | Coverage 0.042 too low. | 0720936e56257bdbc569cfedfe603cf4 | 1089 | Pfam | PF00667 | FAD binding domain | 659 | 882 | 2.0E-62 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/17640|m.6203 | UnnamedSample_HQ_transcript/17640 | Coverage 0.966 too low. | 56ada21ccb4f060a554ae142170b4eb3 | 660 | Pfam | PF13246 | Cation transport ATPase (P-type) | 59 | 167 | 1.7E-18 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/17640|m.6203 | UnnamedSample_HQ_transcript/17640 | Coverage 0.966 too low. | 56ada21ccb4f060a554ae142170b4eb3 | 660 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 232 | 354 | 5.6E-15 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/17640|m.6203 | UnnamedSample_HQ_transcript/17640 | Coverage 0.966 too low. | 56ada21ccb4f060a554ae142170b4eb3 | 660 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 424 | 627 | 1.3E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/55467|m.15125 | UnnamedSample_HQ_transcript/55467 | Coverage 0.711 too low. | 959354ee3f34f95bba98d9e8eab1938e | 586 | Pfam | PF00474 | Sodium:solute symporter family | 38 | 445 | 1.7E-28 | T | 22-09-2020 | IPR001734 | Sodium/solute symporter |
| UnnamedSample_HQ_transcript/118865|m.24765 | UnnamedSample_HQ_transcript/118865 | Coverage 0.990 too low. | bf21c13cd6d8ee64980e7adaa04e2847 | 204 | Pfam | PF01545 | Cation efflux family | 44 | 119 | 1.3E-15 | T | 22-09-2020 | IPR002524 | Cation efflux protein |
| UnnamedSample_HQ_transcript/51030|m.14252 | UnnamedSample_HQ_transcript/51030 | Coverage 0.934 too low. | 593c03cd34ffb40c4158a6da6b49a66a | 602 | Pfam | PF04677 | Protein similar to CwfJ C-terminus 1 | 378 | 500 | 1.6E-34 | T | 22-09-2020 | IPR006768 | Cwf19-like, C-terminal domain-1 |
| UnnamedSample_HQ_transcript/51030|m.14252 | UnnamedSample_HQ_transcript/51030 | Coverage 0.934 too low. | 593c03cd34ffb40c4158a6da6b49a66a | 602 | Pfam | PF04676 | Protein similar to CwfJ C-terminus 2 | 509 | 600 | 2.8E-24 | T | 22-09-2020 | IPR006767 | Cwf19-like protein, C-terminal domain-2 |
| UnnamedSample_HQ_transcript/101646|m.22828 | UnnamedSample_HQ_transcript/101646 | Coverage 0.966 too low. | 1fdaae83bb74ff23887b9a49b5958070 | 257 | Pfam | PF00170 | bZIP transcription factor | 67 | 127 | 6.9E-14 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/81374|m.19941 | UnnamedSample_HQ_transcript/81374 | Identity 0.947 too low. | 1fdaae83bb74ff23887b9a49b5958070 | 257 | Pfam | PF00170 | bZIP transcription factor | 67 | 127 | 6.9E-14 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/13789|m.5048 | UnnamedSample_HQ_transcript/13789 | Coverage 0.211 too low. | ee86def857530fb82bf03d6560daac8e | 1021 | Pfam | PF04821 | Timeless protein | 2 | 88 | 2.1E-16 | T | 22-09-2020 | IPR006906 | Timeless, N-terminal |
| UnnamedSample_HQ_transcript/13789|m.5048 | UnnamedSample_HQ_transcript/13789 | Coverage 0.211 too low. | ee86def857530fb82bf03d6560daac8e | 1021 | Pfam | PF05029 | Timeless PAB domain | 804 | 884 | 5.6E-21 | T | 22-09-2020 | IPR007725 | Timeless, C-terminal |
| UnnamedSample_HQ_transcript/17237|m.6077 | UnnamedSample_HQ_transcript/17237 | Coverage 0.223 too low. | ee86def857530fb82bf03d6560daac8e | 1021 | Pfam | PF04821 | Timeless protein | 2 | 88 | 2.1E-16 | T | 22-09-2020 | IPR006906 | Timeless, N-terminal |
| UnnamedSample_HQ_transcript/17237|m.6077 | UnnamedSample_HQ_transcript/17237 | Coverage 0.223 too low. | ee86def857530fb82bf03d6560daac8e | 1021 | Pfam | PF05029 | Timeless PAB domain | 804 | 884 | 5.6E-21 | T | 22-09-2020 | IPR007725 | Timeless, C-terminal |
| UnnamedSample_HQ_transcript/47521|m.13467 | UnnamedSample_HQ_transcript/47521 | Identity 0.943 too low. | 38b625d2b0a29647e106844bcaa4f2e4 | 226 | Pfam | PF00372 | Hemocyanin, copper containing domain | 125 | 218 | 8.4E-21 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
